Seeing Is Believing

Currently out of the existing stock ratings of Thomas Yip, 10 are a BUY (100%).
Analyst Thomas Yip, currently employed at B. RILEY, carries an average stock price target met ratio of 33.33% that have a potential upside of 31.57% achieved within 255 days.
Thomas Yip’s has documented 20 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OMER, Omeros at 17-Oct-2016.
Analyst best performing recommendations are on GERN (GERON).
The best stock recommendation documented was for GERN (GERON) at 9/19/2016. The price target of $5 was fulfilled within 549 days with a profit of $3 (150%) receiving and performance score of 2.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-May-2026
$4
$1.82 (83.49%)
5 months 22 days ago
(01-May-2026)
0/2 (0%)
$1.28 (47.06%)
Buy Since 03-Aug-2018
$5
$2.08 (71.23%)
$5
1 years 1 months 11 days ago
(12-Sep-2025)
0/5 (0%)
$3.77 (306.50%)
Buy Since 15-Jun-2020
$4
$1.82 (83.49%)
$4
1 years 2 months 12 days ago
(11-Aug-2025)
0/7 (0%)
$2.75 (220.00%)
Buy Since 08-Nov-2023
$4
$1.08 (36.99%)
$4
1 years 8 months 2 days ago
(21-Feb-2025)
1/3 (33.33%)
$2.35 (142.42%)
933
Buy Since 28-Aug-2019
$3
$0.08 (2.74%)
$6
2 years 6 days ago
(17-Oct-2024)
3/10 (30%)
$1.37 (84.05%)
368
What Year was the first public recommendation made by Thomas Yip?